How does the peripheral metabolism—the conversion or compromised conversion of T4 to T3—affect a patient’s response to T4 monotherapy? How does that set the stage for combination T4 plus T3 therapy in appropriately selected patients?

How does the peripheral metabolism—the conversion or compromised conversion of T4 to T3—affect a patient’s response to T4 monotherapy? How does that set the stage for combination T4 plus T3 therapy in appropriately selected patients?

How does the peripheral metabolism—the conversion or compromised conversion of T4 to T3—affect a patient’s response to T4 monotherapy? How does that set the stage for combination T4 plus T3 therapy in appropriately selected patients?


Created by

CMEducation Resources IQ&A Thyroid Hormone Replacement Medical Intelligence Zone

Presenter

Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP

Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP

Founder, Nurse Practitioner Metabolic Medicine AssociatesCo-Chair, Metabolic & Endocrine Disease Summit (MEDS) King George, Virginia